Research / CRS / Fundamental state Inspectable configuration
State dimensions Filing 0000017843-21-000030 General Corporate
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.81% · OPTIONAL · VALID
Operating cash generation 88th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.94% · OPTIONAL · VALID
Revenue growth 15th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-32.35% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
28.85% · OPTIONAL · VALID
Gross margin 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
0.07% · CORE · VALID
Operating margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-16.85% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.34% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.70% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 5.29%
Current 6.81%
Delta 1.53% Cash Generation Increased
Previous 1.08%
Current 16.94%
Delta 15.86% Growth Increased
Previous -39.89%
Current -32.35%
Delta 7.54% Inventory Pressure Decreased
Previous 152.17%
Current 28.85%
Delta -123.32% Margin Decreased
Previous 3.64%
Current 0.07%
Delta -3.57% Profitability Decreased
Previous -11.37%
Current -16.85%
Delta -5.48% Sbc Intensity Increased
Previous 0.68%
Current 0.70%
Delta 0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.